SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-003518
Filing Date
2018-03-16
Accepted
2018-03-16 17:20:12
Documents
78
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 2256407
2 ex10-28.htm EX-10.28 36964
3 ex21-1.htm EX-21.1 2988
4 ex23-1.htm EX-23.1 3677
5 ex31-1.htm EX-31.1 8063
6 ex31-2.htm EX-31.2 7815
7 ex32-1.htm EX-32.1 6616
8 image_005.jpg GRAPHIC 19508
9 image_007.jpg GRAPHIC 14219
10 image_008.jpg GRAPHIC 15358
11 image_009.jpg GRAPHIC 18033
12 image_010.jpg GRAPHIC 40560
  Complete submission text file 0001493152-18-003518.txt   6038384

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE mtnb-20171231.xml EX-101.INS 673770
14 XBRL SCHEMA FILE mtnb-20171231.xsd EX-101.SCH 54151
15 XBRL CALCULATION FILE mtnb-20171231_cal.xml EX-101.CAL 66776
16 XBRL DEFINITION FILE mtnb-20171231_def.xml EX-101.DEF 246763
17 XBRL LABEL FILE mtnb-20171231_lab.xml EX-101.LAB 403946
18 XBRL PRESENTATION FILE mtnb-20171231_pre.xml EX-101.PRE 322487
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38022 | Film No.: 18696669
SIC: 2834 Pharmaceutical Preparations